Literature DB >> 17234869

Cardiovascular risk prediction tools for populations in Asia.

F Barzi, A Patel, D Gu, P Sritara, T H Lam, A Rodgers, M Woodward.   

Abstract

BACKGROUND: Cardiovascular risk equations are traditionally derived from the Framingham Study. The accuracy of this approach in Asian populations, where resources for risk factor measurement may be limited, is unclear.
OBJECTIVE: To compare "low-information" equations (derived using only age, systolic blood pressure, total cholesterol and smoking status) derived from the Framingham Study with those derived from the Asian cohorts, on the accuracy of cardiovascular risk prediction.
DESIGN: Separate equations to predict the 8-year risk of a cardiovascular event were derived from Asian and Framingham cohorts. The performance of these equations, and a subsequently "recalibrated" Framingham equation, were evaluated among participants from independent Chinese cohorts.
SETTING: Six cohort studies from Japan, Korea and Singapore (Asian cohorts); six cohort studies from China; the Framingham Study from the US. PARTICIPANTS: 172,077 participants from the Asian cohorts; 25,682 participants from Chinese cohorts and 6053 participants from the Framingham Study. MAIN
RESULTS: In the Chinese cohorts, 542 cardiovascular events occurred during 8 years of follow-up. Both the Asian cohorts and the Framingham equations discriminated cardiovascular risk well in the Chinese cohorts; the area under the receiver-operator characteristic curve was at least 0.75 for men and women. However, the Framingham risk equation systematically overestimated risk in the Chinese cohorts by an average of 276% among men and 102% among women. The corresponding average overestimation using the Asian cohorts equation was 11% and 10%, respectively. Recalibrating the Framingham risk equation using cardiovascular disease incidence from the non-Chinese Asian cohorts led to an overestimation of risk by an average of 4% in women and underestimation of risk by an average of 2% in men.
INTERPRETATION: A low-information Framingham cardiovascular risk prediction tool, which, when recalibrated with contemporary data, is likely to estimate future cardiovascular risk with similar accuracy in Asian populations as tools developed from data on local cohorts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234869      PMCID: PMC2465638          DOI: 10.1136/jech.2005.044842

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  26 in total

Review 1.  A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score.

Authors:  T F Thomsen; M Davidsen; H Ibsen; T Jørgensen; G Jensen; K Borch-Johnsen
Journal:  J Cardiovasc Risk       Date:  2001-10

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts.

Authors:  Y Liao; D L McGee; R S Cooper; M B Sutkowski
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

4.  Primary and subsequent coronary risk appraisal: new results from the Framingham study.

Authors:  R B D'Agostino; M W Russell; D M Huse; R C Ellison; H Silbershatz; P W Wilson; S C Hartz
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

5.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

6.  Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart.

Authors:  A Menotti; M Lanti; P E Puddu; D Kromhout
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

7.  Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts.

Authors:  Hans-Werner Hense; Helmut Schulte; Hannelore Löwel; Gerd Assmann; Ulrich Keil
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

8.  Risk functions for prediction of cardiovascular disease in elderly Australians: the Dubbo Study.

Authors:  Leon A Simons; Judith Simons; Yechiel Friedlander; John McCallum; Latha Palaniappan
Journal:  Med J Aust       Date:  2003-02-03       Impact factor: 7.738

9.  Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?

Authors: 
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

10.  Blood pressure and cardiovascular disease in the Asia Pacific region.

Authors:  C M M Lawes; A Rodgers; D A Bennett; V Parag; I Suh; H Ueshima; S MacMahon
Journal:  J Hypertens       Date:  2003-04       Impact factor: 4.844

View more
  62 in total

1.  Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association.

Authors:  Latha P Palaniappan; Maria Rosario G Araneta; Themistocles L Assimes; Elizabeth L Barrett-Connor; Mercedes R Carnethon; Michael H Criqui; Gordon L Fung; K M Venkat Narayan; Hamang Patel; Ruth E Taylor-Piliae; Peter W F Wilson; Nathan D Wong
Journal:  Circulation       Date:  2010-08-23       Impact factor: 29.690

2.  Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china.

Authors:  Andrew Moran; Dongfeng Gu; Dong Zhao; Pamela Coxson; Y Claire Wang; Chung-Shiuan Chen; Jing Liu; Jun Cheng; Kirsten Bibbins-Domingo; Yu-Ming Shen; Jiang He; Lee Goldman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-05-04

3.  Assessment of cardiovascular risk in low resource settings "So much to do - So little done".

Authors:  V Hariram; Sreenivas Kumar Arramraju
Journal:  Indian Heart J       Date:  2016-01-18

4.  Cardiovascular risk factors in middle age obese Indians: a cross-sectional study on association of per cent body fat and intra-abdominal fat mass.

Authors:  Jaspal Singh Sandhu; Vandana Esht; Shweta Shenoy
Journal:  Heart Asia       Date:  2012-02-21

5.  A literature review of the cardiovascular risk-assessment tools: applicability among Asian population.

Authors:  Siow Yen Liau; M I Mohamed Izham; M A Hassali; A A Shafie
Journal:  Heart Asia       Date:  2010-07-06

6.  Ten-year cardiovascular risk in the general public of Hong Kong.

Authors:  Vivian W Y Lee; Sally L T Law
Journal:  Heart Asia       Date:  2011-01-01

7.  Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.

Authors:  P McEwan; H Bennett; T Ward; K Bergenheim
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

Review 8.  Assessment of cardiovascular risk.

Authors:  Marie Therese Cooney; Helen C Cooney; Alexandra Dudina; Ian M Graham
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

9.  Development of new risk score for pre-test probability of obstructive coronary artery disease based on coronary CT angiography.

Authors:  Shinichiro Fujimoto; Takeshi Kondo; Hideya Yamamoto; Naoyuki Yokoyama; Yasuhiro Tarutani; Kazuhisa Takamura; Yoji Urabe; Kumiko Konno; Yuji Nishizaki; Tomohiro Shinozaki; Yasuki Kihara; Hiroyuki Daida; Takaaki Isshiki; Shinichi Takase
Journal:  Heart Vessels       Date:  2014-04-27       Impact factor: 2.037

10.  Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study.

Authors:  Xun Tang; Daniel T Laskowitz; Liu He; Truls Østbye; Janet Prvu Bettger; Yang Cao; Na Li; Jingrong Li; Zongxin Zhang; Jianjiang Liu; Liping Yu; Haitao Xu; Yonghua Hu; Larry B Goldstein
Journal:  Int J Stroke       Date:  2014-08-04       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.